Folic acid-enhanced synergy for the combination of trimetrexate plus the glycinamide ribonucleotide formyltransferase inhibitor 4-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimidino[5,4,6][1,4]thiaxin-6-yl)-(S)-ethyl]-2,5-thienoylamino-L-glutamic acid (AG2034): Comparison across sensitive and resistant human tumor cell lines

Autor: Faessel, H. M., Slocum, H. K., Rustum, Y. M., Greco, W. R.
Zdroj: Biochemical Pharmacology; 1999, Vol. 57 Issue: 5 p567-578, 12p
Databáze: Supplemental Index
Externí odkaz: